title: Anti-HIV drug particles may overcome lymphatic drug insufficiency and associated HIV persistence.
authors.affiliation: Department of Pharmaceutics, University of Washington, Seattle, WA 98195.
authors.forename: Jennifer P
authors.initials: JP
authors.lastname: Freeling
authors.affiliation: Department of Pharmaceutics, University of Washington, Seattle, WA 98195 rodneyho@u.washington.edu.
authors.forename: Rodney J Y
authors.initials: RJ
authors.lastname: Ho
mesh_terms: D019380:Anti-HIV Agents / Q000493:pharmacokinetics*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D008221:Lymphoid Tissue / Q000378:metabolism*; D008297:Male; D014779:Virus Replication
chemical_list: D019380:Anti-HIV Agents